Alexander M. Lesokhin, Jonathan L. Kaufman, Ashraf Badros, Jorge Acosta, Patrick Müller, Carolyn Lou, Ashleigh O'Connell, Gabriel Afram, Attaya Suvannasankha. "MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps7566